Allarity Therapeutics, Inc. Other Noncash Income (Expense)
Allarity Therapeutics, Inc. (ALLR) reported Other Noncash Income (Expense) of -$1.11 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2024-03-08
- Allarity Therapeutics, Inc. other noncash income (expense) for the quarter ending 2023-12-31 was $0.00.
- Allarity Therapeutics, Inc. other noncash income (expense) for the quarter ending 2023-09-30 was -$734.00K.
- Allarity Therapeutics, Inc. other noncash income (expense) for the quarter ending 2023-06-30 was -$372.00K.
- Allarity Therapeutics, Inc. other noncash income (expense) for the quarter ending 2023-03-31 was -$4.00K.
- Allarity Therapeutics, Inc. other noncash income (expense) for fiscal 2023 was -$1.11M.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$734.00K derived: sum of 2 quarters · filed 2024-03-08 | -$1.11M derived: sum of 3 quarters · filed 2024-03-08 | -$1.11M 10-K · filed 2024-03-08 |
| 2023-09-30 | -$734.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.11M derived: sum of 2 quarters · filed 2023-11-14 | -$1.11M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$372.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$376.00K 10-Q · filed 2023-08-14 | ||
| 2023-03-31 | -$4.00K 10-Q · filed 2023-05-11 | |||
| 2021-09-30 | $87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$306.00K derived: sum of 2 quarters · filed 2022-11-14 | -$393.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$393.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-07 | -$480.00K 10-Q · filed 2022-10-07 | ||
| 2021-03-31 | -$87.00K 10-Q · filed 2022-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |